Discontinuation report MINT-METFORMIN
Report ID | 88513 |
Drug Identification Number | 02388766 |
Brand name | MINT-METFORMIN |
Common or Proper name | Metformin |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | METFORMIN HYDROCHLORIDE |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 count bottles. |
ATC code | A10BA |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2019-07-04 |
Remaining supply date | 2019-02-04 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-07-04 | English | Compare |
v2 | 2019-07-04 | French | Compare |
v3 | 2019-07-05 | English | Compare |
Showing 1 to 3 of 3